First Iluvien orders shipped to U.K.


Alimera Sciences (ALIM +13.5%) says it has begun shipping the first orders of Iluvien to U.K. NHS facilities.

The company also says "the first NHS patient received an implant for the treatment of DME" on January 10.

For reference: NICE guidance allows for patients with a pseudophakic eye to receive Iluvien when their chronic DME is "considered insufficiently responsive to available therapies." (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs